ENZYME LINKED IMMUNOSORBENT ASSAY MARKET ANALYSIS
Global Enzyme Linked Immunosorbent Assay (ELISA) Market is estimated to be valued at US$ 2,016.1 million in 2022 and is expected to exhibit a CAGR of 5.1% during the forecast period (2022-2030).
Figure 1. Global Enzyme Linked Immunosorbent Assay (ELISA) Market Share (%), by Method, 2022
-market-fig-1.png)
Increasing product development activities for ELISA kit are expected to drive growth of the Global Enzyme Linked Immunosorbent Assay (Elisa) Market.
Increasing product development activities for ELISA kit are expected to drive growth of the global Enzyme Linked Immunosorbent Assay (ELISA) market. For instance, On May 21, 2021, The Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organization (DRDO), India had developed an antibody detection-based kit 'DIPCOVAN', the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance. The DIPCOVAN kit can detect both spike as well as nucleocapsid proteins of SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%. The kit had been developed in association with Vanguard Diagnostics Pvt Ltd, a diagnostics development and manufacturing company.
Figure 2.Global Enzyme Linked Immunosorbent Assay (ELISA) Market Share (%), by Region, 2022
-market-fig-2.png)
Enzyme Linked Immunosorbent Assay Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :